Chemomab Therapeutics OverviewChemomab Therapeutics Other Income Expense Net
Other Income/Expense Net for CMMB.
Quarterly Other Income/Expense
$76791.00
↓ 53.18% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$485422.00
↑ 116.55% YoY
Trailing 12 months ending Mar 31, 2026